What is the difference between radiotherapy equipment Varian Halcyon and Ankerui Tomotherapy?

The primary distinction between the Varian Halcyon and Accuray Tomotherapy systems lies in their fundamental technological architectures and clinical operational philosophies, which are designed to address different segments of the modern radiotherapy workflow. The Halcyon is a ring-gantry linear accelerator built for high-throughput, standardized intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT). Its design philosophy emphasizes operational simplicity, speed, and reliability, featuring a fully enclosed ring structure that rotates at a constant dose rate, with a flattening filter-free beam and a dual-layer multi-leaf collimator (MLC) for rapid beam shaping. In stark contrast, the Tomotherapy platform, exemplified by the Radixact system, is fundamentally a CT scanner integrated with a megavoltage treatment beam, employing a helical delivery pattern. Its core technology is a binary MLC with pneumatically driven leaves that open and shut very rapidly as the gantry continuously rotates and the couch moves, enabling highly conformal delivery of IMRT with integrated daily megavoltage CT (MVCT) imaging for precision.

The mechanistic differences in delivery and imaging directly translate to divergent clinical applications and workflow integration. The Halcyon’s strength is its efficiency in treating a high volume of patients requiring conventional fractionation for sites like breast, prostate, and head and neck cancers, with treatments often completed in minutes. Its imaging utilizes a novel dual-energy kilovoltage cone-beam CT (CBCT) system mounted on the ring, providing fast, low-dose imaging for patient alignment. Tomotherapy, through its helical IMRT delivery and inherent MVCT imaging, excels at treating large, complex, and continuous target volumes, such as those in total body irradiation, total marrow irradiation, or extensive pleural cases, where its ability to sculpt dose over long, cylindrical geometries is advantageous. Its daily MVCT provides inherently registered images for setup, though with lower soft-tissue contrast compared to kV imaging and a higher imaging dose.

From a facility perspective, the implications of choosing one platform over the other are significant. Implementing a Halcyon is often geared towards streamlining operations in a busy department, reducing machine complexity, and minimizing inter-operator variability through its highly standardized and automated workflow. The Tomotherapy platform, while also capable of high precision, traditionally demands a more specialized physics and dosimetry support structure to optimize its unique planning and delivery parameters, and its treatment times for complex plans can be longer. It occupies a niche for particularly challenging cases that benefit from its continuous delivery mode. Therefore, the selection is less about one system being universally superior and more about aligning technological capabilities with a clinic’s specific patient population, operational priorities, and technical support infrastructure. A department prioritizing throughput and standardization for a broad caseload may lean toward the Halcyon, while one with a referral base requiring sophisticated, image-guided helical IMRT for complex anatomies may find the Tomotherapy platform indispensable.